Novel and selective inhibitors of KRASG12D

被引：0
|
作者：
Bhavar, Prashant Kashinath [1 ]
Surampudi, Uday Kumar [1 ]
Sarma, Partha Pratim [2 ]
Shidore, Mahesh Mohan [2 ]
Kshirsagar, Anuj Ramesh [3 ]
机构：
[1] VRise Therapeut Inc, Cambridge, MA USA
[2] VeGen Therapeut Pvt Ltd, Hyderabad, Telangana, India
[3] VeGen Therapeut Inc, Hyderabad, Telangana, India
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2681
引用
收藏
页数：1
相关论文
共 50 条
  • [31] iExplore: A phase I study of mesenchymal stem cell derived exosomes with KrasG12D siRNA for metastatic pancreas cancer patients harboring the KrasG12D mutation
    Smaglo, Brandon G.
    LeBleu, Valerie S.
    Lee, J. Jack
    Maitra, Anirban
    Kalluri, Raghu
    Rezvani, Katy
    Soto, Luisa M. Solis
    Hurd, Mark
    Kaur, Indreshpal
    Vilchez, Mayela C. Mendt
    Kirtley, Michelle L.
    Shaftoe, Stacy L.
    Morelli, Maria Pia
    Overman, Michael J.
    Zhou, Dan
    Wolff, Robert A.
    Tu, Janet
    Willis, Jason A.
    Huey, Ryan W.
    Lee, Michael S.
    Bhosale, Priya R.
    Dworsky, Suzanne W.
    Xu, Li
    Pant, Shubham
    Shpall, Elizabeth J.
    CANCER RESEARCH, 2024, 84 (02)
  • [32] Discovery of potent and noncovalent KRASG12D inhibitors: Structure-based virtual screening and biological evaluation
    Wang, Yuting
    Zhang, Hai
    Li, Jindong
    Niu, Miao-Miao
    Zhou, Yang
    Qu, Yuanqian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] KRAS Mutant Gene Editing Abolishes Tumor Growth In Vivo and Overcomes Acquired Resistance to KRASG12C and KRASG12D Small Molecule Inhibitors
    Desai, Neil
    Grunenberger, Audrey
    Guzman-Gonzalez, Veronica
    Cabrera, Lea
    Czuba, Elodie
    Faure, Virginie
    Josserand, Veronique
    Di Vita, Gilles
    MOLECULAR THERAPY, 2024, 32 (04) : 226 - 226
  • [34] Canonical Notch Signaling Is Required for KrasG12D - Induced Myeloproliferative Neoplasm
    You, Xiaona
    Kong, Guangyao
    Wen, Zhi
    Chang, Yuan-I
    Ranheim, Erik A.
    Padron, Eric
    Zhang, Jing
    BLOOD, 2017, 130
  • [35] KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
    Lasse-Opsahl, Emily L.
    Barravecchia, Ivana
    Mclintock, Elyse
    Lee, Jennifer M.
    Ferris, Sarah F.
    Espinoza, Carlos E.
    Hinshaw, Rachael
    Cavanaugh, Sophia
    Robotti, Marzia
    Rober, Lily
    Brown, Kristee
    Abdelmalak, Kristena Y.
    Galban, Craig J.
    Frankel, Timothy L.
    Zhang, Yaqing
    Magliano, Marina Pasca di
    Galban, Stefanie
    JCI INSIGHT, 2025, 10 (01)
  • [36] NUDT7 Loss Promotes KrasG12D CRC Development
    Song, Jinsoo
    Park, Sujeong
    Oh, Jinjoo
    Kim, Deokha
    Ryu, Ji Hyun
    Park, Won Cheol
    Baek, In-Jeoung
    Cheng, Xi
    Lu, Xin
    Jin, Eun-Jung
    CANCERS, 2020, 12 (03)
  • [37] The Role Of Eosinophils In Krasg12d Induced Lung Tumor Initiation And Progression
    Li, F.
    Du, X.
    Zhang, C.
    Li, W.
    Chen, Z.
    Ying, S.
    Shen, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [38] KRASG12D GENE DOSAGE DRIVES PANCREATIC TUMOR EVOLUTION AND PROGRESSION
    不详
    CANCER DISCOVERY, 2018, 8 (03) : 265 - 265
  • [39] Differential Cell Susceptibilities to KrasG12D in the Setting of Obstructive Chronic Pancreatitis
    Shi, Chanjuan
    Pan, Fong Cheng
    Kim, Jessica N.
    Washington, M. Kay
    Padmanabhan, Chandrasekhar
    Meyer, Christian T.
    Kopp, Jane L.
    Sander, Maike
    Gannon, Maureen
    Beauchamp, R. Daniel
    Wright, Christopher, V
    Means, Anna L.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2019, 8 (04): : 579 - 594
  • [40] Pulmonary Inflammation And Cancer Cachexia In Krasg12d Induced Lung Adenocarcinoma
    Van der Velden, J. L.
    Langen, R.
    Kelders, M. C.
    Lahue, K. G.
    Janssen-Heininger, Y. M. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345